Characterization of indomethacin release from polyethylene glycol tablet fabricated with mold technique

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 1, 2010, Pages 92-100

  Mesnukul, A ^a   Yodkhum, K ^a   Mahadlek, J ^a   Phaechamud, T ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

Author keywords

Indomethacin; Mold tablet; Polyethylene glycol; Release; Xanthan gum

Indexed keywords

EUDRAGIT; INDOMETACIN; MACROGOL 4000; PHOSPHATE; XANTHAN;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DIFFUSION; DRUG SOLUBILITY; MELTING POINT; PH; SUSTAINED DRUG RELEASE; TABLET FORMULATION; TABLET HARDNESS; TABLET MANUFACTURE; TABLET MATRIX; TABLET POROSITY; TABLET SURFACE; TABLET THICKNESS;

EID: 77951668379     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.62255     Document Type: Article

References (36)

1. Craig DG. Polyethylene glycols and drug release. Drug Develop Ind Pharm 1990;16:2501-2526
2. Fujii M, Okada H, Shibata Y, Teramachi H, Kondoh M, Watanabe Y. Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone. Int J Pharm 2005;293:145-153 (Pubitemid 40381088)
3. Trapani G, Franco M, Latrofa A, Pantaleo MR, Provenzano MR, Sanna E, et al. Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000. Int J Pharm 1999;184:121-130
4. Wang X, Armasa HN, Blaton H, Michoel A, Van dan Mooter G. Phase characterization of indomethacin in binary solid dispersions with PVP VA64 or Myrj 52. Int J Pharm 2007;123:163-169
5. Fini A, Moyano JR, Gines JM, Perez-Martinez JI, Rabasco AM. Diclofenac salts, II: solid dispersions in PEG6000 and Gelucire 50/13. Eur J Pharm Biopharm 2005;60:99-111.
6. Leonardi D, Barrera MG, Lamas MC, Salomon CJ. Development of prednisolone: polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters. AAPS PharmSciTech 2007;8(4) Article 108 (http://www. aapspharmscitech.org) [last accessed on 2009 Jan 4].
7. Ahuja N, Katare O P, Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 2007;65:26-38.
8. Mesnukul A, Yodkhum K, Phaechamud T. Solid dispersion matrix tablet comprising indomethacin-PEG-HPMC fabricated with fusion and mold technique. Indian J Pharm Sci 2009;71:413-420
9. Stokke BT, Christensen BE, Smidsrod O. Macromolecular properties of xanthan gum. In S. Dumitriu, Polysaccharides. New York: Marcel Dekker; 1998, pp. 433-472
10. Garcia-Ochoa F, Santos VE, Casas JA, Gomez E. Xanthan gum: production, recovery, and properties. Biotechnol Adv 2000;18:549-579
11. El-Gazayerly ON. Release of pentoxifylline from xanthan matrix. Drug Develop Ind Pharm 2003;29:241-246
12. MicroMath Scientist Handbook Rev. 7EEF, Salt Lake City: MicroMath; 1995, pp: 467.
13. Ohta KM, Fuji M, Takei T, Chikazawa M. Development of a simple method for the preparation of a silica gel based controlled delivery system with a high drug content. Eur J Pharm Sci 2005;26:87-96.
14. Baumgartner S, Pavli M, Kristl J. Effect of calcium ions on the gelling and drug release characteristics of xanthan matrix tablets. Eur J Pharm Biopharm 2008;69:698-707.
15. Talukdar MM, Van den Mooter P, Augustijns T, Tjandra-Maga G. In vivo evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formulation. Int J Pharm 1998;169:105-113
16. Tobyn MJ, Staniforth JN, Baichwal AR, McCall TW. Prediction of physical properties of a novel polysaccharide controlled release system. I. Int J Pharm 1996;128:113-120
17. Billa N, Yuen KH. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS PharmSciTech 2000;4:120-127
18. Walker M, Wells J. Xanthan alginate composite gel beads: Molecular interaction and in vitro characterization. Int J Pharm 1982;331:61-71.
19. Fu XC, Wang GP, Liang WQ, Chow MS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release 2004;95:209-216
20. Sinha VR, Kumria R. Coating polymers for colon specific drug delivery: A comparative in vitro evaluation. Acta Pharm Sci 2003;53:41-47
21. Dourado F, Bastos M, Mota M, Gama FM. Studies on the properties of Celluclast/Eudragit L-100 conjugate. J Biotechnol 2002;99:121-131
22. Hadjiioannou TP, Christian GD, Koupparis MA. Quantitative calculations in pharmaceutical practice and research. New York: VCH Publishers Inc; 1993, p. 345-348
23. Bourne DW. Pharmacokinetics. Modern Pharmaceutics, New York: Informa Healthcare; 2002, p. 67-92.
24. Cox PL, Khan KA, Munday DL, Sujja-areevath J. Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics. Int J Pharm 1999;193:73-84.
25. Charmbin O, Champion D, Debray C, Rochat-Gonthier MH, Meste ML, Pourcelot Y. Effect of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J Control Release 2004;95:101-108
26. Colombo P, Bettini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Tech Today 2000;6:32-38.
27. Yeole PG, Galgatte UC, Babla IB, Nakhat PD. Design and evaluation of xanthan gum-based sustained release matrix tablet of diclofenac sodium. Indian J Pharm Sci 2006;68:185-189
28. Maggi L, Segale L, Torre ML, Ochoa ME, Conte U. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. Biomater 2002;23:1113-1119
29. Siepmann J, Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Del Rev 2001;48:139-157
30. Li H, Gu X. Correlation between drug dissolution and polymer hydration: A study using texture analysis. Int J Pharm 2007;342:18-25.
31. Eis MJ, Watkins BM, Philip A, Welling RE. Non-steroidal induced benign structures of colon: a case report and review of the literature. Am J Gastroenterol 1998;93:120-121
32. Okimoto K, Miyake M, Ibuki R, Ohnishi N, Nakai T. Dissolution mechanism and rate of solid dispersion particles of nifednipine with hydroxypropylmethylcellulose. Int J Pharm 1997;159:85-93.
33. Kohri N, Yamayoshi Y, Xin H, Iseki K, Sato N, Toda S, Miyazaki K. Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol 1999;51:159-164
34. Zheng L, Wang YZ, Yang KK, Wang XL, Chen S-C, Li J. Effect of PEG on the crystallization of PPDO/PEG blends. Eur Polym J 2005;41:1243-1250
35. Verma RK, Garg S. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. J Pharm Biomed Anal 2005;38:633-644
36. Sankalia JM, Sankalia MG, Mashru RC. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: Establishment of level A IVIVC. J Control Release 2008;129:49-58.